arrow
G

Gerard Agbayani

National Research Council Canada
H指数:11
被引数:374

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Immunogenicity of Sulfated Lactosyl Archaeol Archaeosome-Adjuvanted Versus Non-Adjuvanted SARS-CoV-2 Spike Booster Vaccines in Young and Aged Balb/c Mice

Stark, F.C.; Akache, B.; Renner, T.M.; Agbayani, G.; Deschatelets, L.; Dudani, R.; Harrison, B.A.; Hemraz, U.D.; Regnier, S.; Stuible, M.; 等. 硫酸化乳糖基阿奇醇古菌体佐剂与非佐剂的SARS-CoV-2刺突蛋白加强疫苗在年轻和老年Balb/c小鼠中的免疫原性。Vaccines 2025, 13, 1257. [Google Scholar] [CrossRef]

2026-03-040
OAAI
Immunogenicity and Safety of a Third and Subsequent COVID-19 Vaccine Doses in Patients with Plasma Cell Dyscrasias

第三剂及后续剂次的COVID-19疫苗在浆细胞疾病患者中的免疫原性和安全性

2026-02-170
OAAI
Heterologous vs. homologous vaccine regimens: Sulfated lactosyl archaeol (SLA) archaeosome-adjuvanted SARS-CoV-2 spike protein boost following an mRNA/LNP prime induces robust and balanced immune responses

异源与同源疫苗接种方案:在mRNA/LNP初始免疫后,经SLA(硫酸化乳糖基古藻醇)古菌体佐剂加强的SARS-CoV-2刺突蛋白能够诱导强效且平衡的免疫应答

Vaccine
IF3.5
2026-01-070
OAAI
Immunogenicity and safety of third, fourth and subsequent COVID-19 vaccine doses in recipients of hematopoietic cell transplantation and cellular therapy

造血细胞移植和细胞治疗受者接种第三、第四及后续COVID-19疫苗剂量的免疫原性和安全性

2025-11-080
PRE
Intranasal immunization with a proteosome-adjuvanted SARS-CoV-2 spike protein-based vaccine is immunogenic and efficacious in mice and hamsters

以蛋白体为佐剂的SARS-CoV-2刺突蛋白为基础的疫苗鼻内预防接种在小鼠和仓鼠中具有免疫原性和有效性

2022-06-1318
OAAI